Whalegun
Home

Supernus Pharmaceuticals SUPN paid Jeffrey J. Kimbell & Associates $20K for lobbying in Q2 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$20,000
Quarter
Q2 2023
Stock
Supernus Pharmaceuticals SUPN
Client
Supernus Pharmaceuticals
Reported
23/07/20

Up 0.0% from last quarter

What else happened in Supernus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Supernus Pharmaceuticals's other lobbying reports

Supernus Pharmaceuticals SUPN paid Jeffrey J. Kimbell & Associates $20K for lobbying in Q2 2023 · Health Issues, Medicare | Whalegun